Anti-CD105 antibody [EPR22811-18]
- BOND RX™ Validated
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
5
(1 Review)
|
(17 Publications)
Rabbit Recombinant Monoclonal CD105 antibody. Suitable for IP, Flow Cyt, WB, ICC/IF, IHC-P and reacts with Human samples. Cited in 17 publications.
View Alternative Names
CD105, END, ENG, Endoglin
- Flow Cyt
Unknown
Flow Cytometry - Anti-CD105 antibody [EPR22811-18] (AB231774)
Flow cytometric analysis of Jurkat (human T cell leukemia T lymphocyte, Left) / HUVEC (human umbilical vein endothelial cell, Right) cells labeling CD105 with ab231774 at 1/500 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody.
Negative control : Jurkat (PMID : 28351936). Gated on viable cells.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD105 antibody [EPR22811-18] (AB231774)
Immunohistochemical analysis of paraffin-embedded human ovarian carcinoma tissue labeling CD105 with ab231774 at 1/100 dilution (5.1 μg/ml) followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on endothelial cells of human ovarian carcinoma (PMID : 17502949). The section was incubated with ab231774 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20mins.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CD105 antibody [EPR22811-18] (AB231774)
Immunofluorescent analysis of 100% methanol-fixed U-937 (human histiocytic lymphoma monocyte) cells labeling CD105 with ab231774 at 1/500 dilution, followed by a ab150077 AlexaFluor®488 Goat anti-Rabbit secondary antibody at 1/1000 dilution (Green). Confocal image showing membranous staining in U-937 cells is observed. ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (Red). The nuclear counterstain was DAPI (Blue).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is ab150077 AlexaFluor®488 Goat anti-Rabbit secondary at 1/1000 dilution.
Negative control : Jurkat (PMID : 28351936).
- Flow Cyt
Unknown
Flow Cytometry - Anti-CD105 antibody [EPR22811-18] (AB231774)
Flow cytometric analysis of U-937 (human histiocytic lymphoma monocyte) cells labeling CD105 with ab231774 at 1/500 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody. Gated on viable cells.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD105 antibody [EPR22811-18] (AB231774)
Immunohistochemical analysis of paraffin-embedded human placenta tissue labeling CD105 with ab231774 at 1/100 dilution (5.1 μg/ml) followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on human placental trophoblasts (PMID : 17956952) is observed. The section was incubated with ab231774 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20mins.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
- IP
Unknown
Immunoprecipitation - Anti-CD105 antibody [EPR22811-18] (AB231774)
CD105 was immunoprecipitated from 0.35 mg HUVEC (human umbilical vein endothelial cell) whole cell lysate with ab231774 at 1/30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab231774 1/1000 dilution (0.51 μg/ml). VeriBlot for IP secondary antibody (HRP) (ab131366) was used as the secondary antibody at 1/5000 dilution.
Lane 1 : HUVEC (human umbilical vein endothelial cell) whole cell lysate 10μg
Lane 2 : ab231774 IP in HUVEC whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab231774 in HUVEC whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 mins.
All lanes:
Immunoprecipitation - Anti-CD105 antibody [EPR22811-18] (ab231774)
Predicted band size: 70 kDa
false
- WB
Unknown
Western blot - Anti-CD105 antibody [EPR22811-18] (AB231774)
Blocking/Diluting buffer and concentration : 5% NFDM/TBST.
Exposure times : Lanes 1-3 : 26 secs; Lanes 4-5 : 3 mins.
The molecular weight observed is consistent with what has been described in the literature (PMID : 8932339).
This blot was developed using a higher sensitivity ECL substrate.
Negative control : Jurkat (PMID : 28351936); Raji (PMID : 28351936).
All lanes:
Western blot - Anti-CD105 antibody [EPR22811-18] (ab231774) at 1/1000 dilution
Lane 1:
HUVEC (human umbilical vein endothelial cell), whole cell lysate 20 μg
Lane 2:
Jurkat (human T cell leukemia T lymphocyte), whole cell lysate 20 μg
Lane 3:
Raji (human Burkitt's lymphoma B lymphocyte), whole cell lysate 20 μg
Lane 4:
Human lung tissue lysate 20 μg
Lane 5:
Human placenta tissue lysate 20 μg
Secondary
Lanes 1 - 3:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Lanes 4 - 5:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 70 kDa
false
- WB
Unknown
Western blot - Anti-CD105 antibody [EPR22811-18] (AB231774)
Blocking/Diluting buffer and concentration : 5% NFDM/TBST.
The molecular weight observed is consistent with what has been described in the literature (PMID : 8932339).
All lanes:
Western blot - Anti-CD105 antibody [EPR22811-18] (ab231774) at 1/1000 dilution
All lanes:
U937 (human histiocytic lymphoma monocyte), whole cell lysate 40 μg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 70 kDa
Observed band size: 97 kDa
false
Exposure time: 103s
Related conjugates and formulations (5)
-
Anti-CD105 antibody [EPR22811-18] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD105 antibody [EPR22811-18]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CD105 antibody [EPR22811-18]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD105 antibody [EPR22811-18]
-
578 PE
PE Anti-CD105 antibody [EPR22811-18]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Endoglin functions in the regulation of angiogenesis and vascular remodeling. It plays a significant role in mediating cellular responses to TGF-beta signaling influencing endothelial cell proliferation and migration. While not part of a larger structural complex endoglin interacts with receptors and signaling molecules important for vascular development and repair processes. This involvement aids in maintaining endothelial integrity and function under various physiological conditions.
Pathways
CD105 participates in the TGF-beta signaling and angiogenesis pathways. In these pathways it acts in conjunction with other proteins like TGF-beta receptors which play roles in cell differentiation proliferation and apoptosis. The interaction between CD105 and TGF-beta signaling regulates numerous cellular mechanisms impacting angiogenesis and cellular responses to environmental changes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Molecular neurodegeneration 20:84 PubMed40702549
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:6769 PubMed40695833
2025
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 20:e0316607 PubMed39804876
2025
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38:e70274 PubMed39724514
2024
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 15:455 PubMed39609719
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic surgery and research 18:937 PubMed38062424
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in neuroscience 17:1172740 PubMed37457010
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medical technology 5:1194314 PubMed37378005
2023
Applications
Unspecified application
Species
Unspecified reactive species
Adipocyte 12:2173513 PubMed36775902
2023
Applications
Unspecified application
Species
Unspecified reactive species
Neural regeneration research 18:618-625 PubMed36018186
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com